These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 960908)

  • 1. [The effect of flavonoid compounds (+)-cyanidanol-3 in acute viral hepatitis].
    Borel GA; Schelling JL; Magnenat P
    Z Gastroenterol; 1976 Jan; 14(1):24-9. PubMed ID: 960908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)].
    Magliulo E; Gagliardi B; Fiori GP
    Med Klin; 1978 Jul; 73(28-29):1060-5. PubMed ID: 353464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
    Aguilar Reina J; de la Santa López J; Cuadras Avellana CM; Kern A
    Fortschr Med; 1978 Jan; 96(2):75-9. PubMed ID: 74352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I; Schmidt FW; Müller R; Ranft U; Wildhirt E; Holzer E; Wallnöfer H; Korb G
    Dtsch Med Wochenschr; 1980 Mar; 105(10):330-2. PubMed ID: 6153953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M; Kisfaludy S; Szalay F
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A; Paál M; Kádas I; Kerekes E; Jávor T
    Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of acute viral hepatitis with laevulose infusions (author's transl)].
    Bode JC; Bungartz G; Dölle W
    Dtsch Med Wochenschr; 1976 Jan; 101(2):43-7. PubMed ID: 1245154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of (+)-cyanidanol-3 on acute hepatitis. Results of a double blind study (author's transl)].
    Rehmann I; Heinkel K
    Med Klin; 1977 Dec; 72(50):2159-64. PubMed ID: 339045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
    Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hyperbilirubinemia in acute inflammation of appendix: a prospective study of 45 cases.
    Khan S
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):281-9. PubMed ID: 18603920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of therapeutic effects of "Cooling the blood and invigorating blood circulation" method on hepatitis hyperbilirubinemia].
    Li YZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):73-4. PubMed ID: 16642224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of (+)-cyanidanol-3 in acute HAV, HBV, and non-A, non-B viral hepatitis.
    Piazza M; Guadagnino V; Picciotto L; De Mercato R; Chirianni A; Orlando R; Golden G
    Hepatology; 1983; 3(1):45-9. PubMed ID: 6401668
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of (+)-cyanidanol-3 on chronic liver injury.
    Kovách G; Salamon F
    Acta Physiol Hung; 1984; 64(3-4):443-8. PubMed ID: 6152368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low lipoprotein (a) levels during acute viral hepatitis.
    Geiss HC; Ritter MM; Richter WO; Schwandt P; Zachoval R
    Hepatology; 1996 Dec; 24(6):1334-7. PubMed ID: 8938156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis.
    Kochar DK; Kaswan K; Kochar SK; Sirohi P; Pal M; Kochar A; Agrawal RP; Das A
    J Vector Borne Dis; 2006 Sep; 43(3):123-9. PubMed ID: 17024861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical problems of tuberculostatic therapy and acute virus hepatitis.
    Schöndorf Th; leinweber B
    Acta Hepatogastroenterol (Stuttg); 1974 Dec; 21(6):411-8. PubMed ID: 4463666
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of (+)-cyanidanol-3- on acute viral hepatitis. Preliminary results].
    Guadagnino V; De Mercato R; Piazza M
    Clin Ter; 1977 Dec; 83(5):463-8. PubMed ID: 608309
    [No Abstract]   [Full Text] [Related]  

  • 20. The behavior of aspartic and alanine aminotransferases, lactic dehydrogenase, cholinesterase, prothrombin, beta-glucuronidase, bilirubin, thymol turbidity test and serum proteinograms under the influence of corticotherapy in the course of viral hepatitis in children.
    Drozdz H; Jedrychowski A; Szreniawska T; Wójcik Z; Baniowski A; Biernacka B
    Acta Med Pol; 1968; 9(2):231-41. PubMed ID: 5670292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.